Children with multi-drug resistant tuberculosis (MDR-TB) undergo months of life-saving treatment including many doses of foul-tasting medications, which caregivers often struggle to prepare and administer accurately. New findings from the Global Alliance for TB Drug Development (TB Alliance) and Stellenbosch University, in South Africa now provide detailed blueprints for pharmacists to quickly and safely prepare more palatable, more accurately dosed syrup suspensions for key drugs against MDR- TB. The researchers hope their work will significantly improve treatment outcomes of children with MDR-TB. Read more here.
top of page
Recent Posts
See AllThis report marks the midway point of the 1/4/6×24 Campaign, which calls for the universal implementation of the best available TB regimens — as little as one month or once weekly for TB prevention, f
20
Their annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB). View the full
30
The Indonesia AIDS Coalition (IAC) and Indonesia for Global Justice (IGJ) have filed a patent opposition for the Tuberculosis (TB) drug Bedaquiline with dispersible tablet formulations (hereinafter, i
380
bottom of page